These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 16007875

  • 1. Transformation in the use of radiation therapy of Hodgkin lymphoma: new concepts and indications lead to modern field design and are assisted by PET imaging and intensity modulated radiation therapy (IMRT).
    Yahalom J.
    Eur J Haematol Suppl; 2005 Jul; (66):90-7. PubMed ID: 16007875
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy.
    Koeck J, Abo-Madyan Y, Lohr F, Stieler F, Kriz J, Mueller RP, Wenz F, Eich HT.
    Int J Radiat Oncol Biol Phys; 2012 May 01; 83(1):268-76. PubMed ID: 22079733
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Recommendations for the use of radiotherapy in nodal lymphoma.
    Hoskin PJ, Díez P, Williams M, Lucraft H, Bayne M, Participants of the Lymphoma Radiotherapy Group.
    Clin Oncol (R Coll Radiol); 2013 Jan 01; 25(1):49-58. PubMed ID: 22889569
    [Abstract] [Full Text] [Related]

  • 7. Clinical impact of FDG-PET/CT in the planning of radiotherapy for early-stage Hodgkin lymphoma.
    Hutchings M, Loft A, Hansen M, Berthelsen AK, Specht L.
    Eur J Haematol; 2007 Mar 01; 78(3):206-12. PubMed ID: 17253974
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The development of quality assurance programs for radiotherapy within the German Hodgkin Study Group (GHSG). Introduction, continuing work, and results of the radiotherapy reference panel.
    Müller RP, Eich HT.
    Strahlenther Onkol; 2005 Sep 01; 181(9):557-66. PubMed ID: 16170482
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [New therapeutic strategies for Hodgkin lymphoma in cooperation of radiation oncology and medical oncology].
    Eich HT, Müller RP, Ansén S, Josting A, Engert A, Hansemann K, Pfistner B, Wolf J, Willich N, Diehl V.
    Rontgenpraxis; 2003 Sep 01; 55(3):114-24. PubMed ID: 15119314
    [Abstract] [Full Text] [Related]

  • 13. Impact of PET-CT on involved field radiotherapy design for pediatric Hodgkin lymphoma.
    Paulino AC, Margolin J, Dreyer Z, Teh BS, Chiang S.
    Pediatr Blood Cancer; 2012 Jun 01; 58(6):860-4. PubMed ID: 21826784
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
    Dawson LA, Saito NG, Ratanatharathorn V, Uberti JP, Adams PT, Ayash LJ, Reynolds CM, Silver SM, Schipper MJ, Lichter AS, Eisbruch A.
    Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):208-18. PubMed ID: 15093918
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Radiotherapy of hodgkin lymphoma: indications, new fields, and techniques.
    Girinsky T, Ghalibafian M.
    Semin Radiat Oncol; 2007 Jul 01; 17(3):206-22. PubMed ID: 17591568
    [Abstract] [Full Text] [Related]

  • 19. Can treatment of pediatric Hodgkin's lymphoma be improved by PET imaging and proton therapy?
    Knäusl B, Lütgendorf-Caucig C, Hopfgartner J, Dieckmann K, Kurch L, Pelz T, Pötter R, Georg D.
    Strahlenther Onkol; 2013 Jan 01; 189(1):54-61. PubMed ID: 23161118
    [Abstract] [Full Text] [Related]

  • 20. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.
    Grills IS, Yan D, Martinez AA, Vicini FA, Wong JW, Kestin LL.
    Int J Radiat Oncol Biol Phys; 2003 Nov 01; 57(3):875-90. PubMed ID: 14529795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.